A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS
- Conditions
- Candidiasis, OralHIV Infections
- Registration Number
- NCT00002282
- Lead Sponsor
- Pfizer
- Brief Summary
To compare the efficacy, safety, and tolerance of fluconazole single daily capsule for 14 days versus clotrimazole troche 5 x daily for 14 days in the treatment of oropharyngeal candidiasis in patients with AIDS.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (17)
Dr Robert Larsen
🇺🇸Los Angeles, California, United States
SUNY / Health Sciences Ctr at Stony Brook
🇺🇸Stony Brook, New York, United States
Buckley Braffman Stern Med Associates
🇺🇸Philadelphia, Pennsylvania, United States
Univ Hosp
🇺🇸Boston, Massachusetts, United States
Davies Med Ctr
🇺🇸San Francisco, California, United States
UCSF Hosp
🇺🇸San Francisco, California, United States
Cornell Univ Med Ctr
🇺🇸New York, New York, United States
Cabrini Med Ctr
🇺🇸New York, New York, United States
Univ TX San Antonio Health Science Ctr
🇺🇸San Antonio, Texas, United States
Infectious Disease Physicians Inc
🇺🇸Annandale, Virginia, United States
Summitt Med Ctr / San Francisco Gen Hosp
🇺🇸Oakland, California, United States
Saint Raphael's Hosp
🇺🇸New Haven, Connecticut, United States
Johns Hopkins Hosp
🇺🇸Baltimore, Maryland, United States
George Washington Univ Med Ctr
🇺🇸Washington, District of Columbia, United States
Washington Univ School of Medicine
🇺🇸St. Louis, Missouri, United States
Saint Michael's Med Ctr
🇺🇸Newark, New Jersey, United States
Ohio State Univ Hosp
🇺🇸Columbus, Ohio, United States